The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $283.61

Today's change+0.60 +0.21%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $283.61

Today's change+0.60 +0.21%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.

Biogen Inc up (U.S.)$0.60

Biogen Inc closed up Wednesday by (U.S.)$0.60 or 0.21% to (U.S.)$283.61. Shares have lost 1.22% for the last five days, but have gained 3.76% over the last 52 weeks. This security has underperformed the S&P 500 by 17.06% during the last year.

Key company metrics

  • Open(U.S.) $284.79
  • Previous close(U.S.) $283.01
  • High(U.S.) $286.16
  • Low(U.S.) $282.87
  • Bid / Ask(U.S.) $280.00 / (U.S.) $288.25
  • YTD % change+0.011%
  • Volume1,079,736
  • Average volume (10-day)1,530,811
  • Average volume (1-month)1,826,694
  • Average volume (3-month)1,641,568
  • 52-week range(U.S.) $223.02 to (U.S.) $333.65
  • Beta0.72
  • Trailing P/E16.04×
  • P/E 1 year forward14.02×
  • Forward PEG1.49×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $17.69
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,9562,8942,7272,839
Total other revenue--------
Total revenue2,9562,8942,7272,839
Gross profit2,5392,5242,4142,508
Total cost of revenue417370313332
Total operating expense1,5311,4341,3481,671
Selling / general / administrative463492497583
Research & development529473437542
Depreciation / amortization100938997
Interest expense (income), net operating--------
Unusual expense (income)181112118
Other operating expenses, total5-6----
Operating income1,4251,4611,3781,168
Interest income (expense), net non-operating-66-66-63-67
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3671,4021,3261,086
Income after tax1,0301,048969829
Income tax, total337354356257
Net income1,0331,050971832
Total adjustments to net income--------
Net income before extra. items1,0331,050971832
Minority interest3123
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0331,050971832
Inc. avail. to common incl. extra. items1,0331,050971832
Diluted net income1,0331,050971832
Dilution adjustment--------
Diluted weighted average shares219219219221
Diluted EPS excluding extraordinary itemsvalue per share4.714.784.433.77
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.774.824.474.17